Finance

Lists
ALLO:NASDAQ
Allogene Therapeutics Inc
၁.၄၀ US$
၀.၀၀%
(၀.၀၀) 1D
အောက် ၈, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALLO...
Mkt. cap
၄၈.၃၇ ကုဋေ
Avg. vol.
၅.၅၀ သန်း
Volume
၁၉၃.၀၀
52-wk high
၄.၄၆ US$
52-wk low
၁.၀၄ US$
EPS
-၀.၆၇ US$
Beta
၀.၅၆
Shares outstanding
၃၄.၅၅ ကုဋေ
No. of employees
၁၅၀
Mkt. cap
၄၈.၃၇ ကုဋေ
Avg. vol.
၅.၅၀ သန်း
Volume
၁၉၃.၀၀
52-wk high
၄.၄၆ US$
52-wk low
၁.၀၄ US$
EPS
-၀.၆၇ US$
Beta
၀.၅၆
Shares outstanding
၃၄.၅၅ ကုဋေ
No. of employees
၁၅၀
News stories
From web sources and news partners
About Allogene Therapeutics Inc
CEO-
Employees၁၅၀
Founded၂၀၁၇
HeadquartersSouth San Francisco, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteallogene.com
Analyst ratings
Based on 7 analysts giving stock ratings to ALLO in the past 3 months
Strong buy
Buy
6
Hold
1
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for ALLO in the last 3 months.
Highest
Current ၁.၄၀ US$
၁၄.၀၀ US$ (+၉၀၀.၀၀%)
Average
၁၀.၂၅ US$ (+၆၃၂.၁၄%)
Lowest
၈.၀၀ US$ (+၄၇၁.၄၃%)
Analyst
Recommendation
Action
Price target
Projected
Date
John Newman
Canaccord Genuity
Buy
Maintained
၁၄.၀၀ US$
+၉၀၀%
09/30/2026
Brian Cheng
J.P. Morgan
Hold
Maintained
-
-
08/17/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
08/12/2026
Unknown Analyst
UBS
Buy
Reiterated
၈.၀၀ US$
+၄၇၁.၄%
08/13/2026
Luca Issi
RBC Capital
Buy
Reiterated
၉.၀၀ US$
+၅၄၂.၉%
08/12/2026
Biren Amin
Piper Sandler
Buy
Maintained
၁၀.၀၀ US$
+၆၁၄.၃%
08/13/2026
Sami Corwin
William Blair
Buy
Maintained
-
-
08/13/2026
Matthew Biegler
Oppenheimer
Buy
Reiterated
၇.၀၀ US$
+၄၀၀%
05/14/2026
Roger Song
Jefferies
Buy
Maintained
၁၀.၀၀ US$
+၆၁၄.၃%
04/15/2026
Jack Allen
Robert W. Baird
Buy
Maintained
၉.၀၀ US$
+၅၄၂.၉%
04/14/2026
William Pickering
Bernstein
Hold
Maintained
၃.၈၅ US$
+၁၇၅%
04/14/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
၁၁.၀၀ US$
+၆၈၅.၇%
04/16/2026
Reni Benjamin
Citizens JMP
Buy
Maintained
၈.၀၀ US$
+၄၇၁.၄%
04/14/2026
Samantha Semenkow
Citi
Buy
Reiterated
၄.၀၀ US$
+၁၈၅.၇%
04/09/2026
Asthika Goonewardene
Truist Financial
Buy
Maintained
၁၀.၀၀ US$
+၆၁၄.၃%
03/13/2026
Last report
၂၀၂၆ ဩ ၁၂
Fiscal period
Q2 2026
-၀.၁၃ US$ / -၀.၁၅ US$
+၁၂.၁၆%beat
Revenue / Est. (USD)
၄.၆၄ သန်း / ၂.၂၂ ထောင်
+၂၀၈,၉၀၉.၀၁%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
၄.၆၄ သန်း
Cost of goods sold
၃.၁၂ ကုဋေ
၂.၈၆ ကုဋေ
၃.၂၀ ကုဋေ
၃.၀၇ ကုဋေ
Cost of revenue
၃.၁၂ ကုဋေ
၂.၈၆ ကုဋေ
၃.၂၀ ကုဋေ
၃.၀၇ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁.၃၇ ကုဋေ
၁.၃၈ ကုဋေ
၁.၄၁ ကုဋေ
၂.၀၈ ကုဋေ
Operating expense
၁.၃၇ ကုဋေ
၁.၃၈ ကုဋေ
၁.၄၁ ကုဋေ
၂.၀၈ ကုဋေ
Total operating expenses
၄.၄၉ ကုဋေ
၄.၂၄ ကုဋေ
၄.၆၁ ကုဋေ
၅.၁၆ ကုဋေ
Operating income
-၄.၄၉ ကုဋေ
-၄.၂၄ ကုဋေ
-၄.၆၁ ကုဋေ
-၄.၆၉ ကုဋေ
Other non operating income
-၈.၁၀ သောင်း
၂.၄၇ သိန်း
၂.၁၂ သိန်း
-၆.၁၀ သောင်း
EBT including unusual items
-၄.၁၄ ကုဋေ
-၃.၈၈ ကုဋေ
-၄.၂၆ ကုဋေ
-၄.၂၇ ကုဋေ
EBT excluding unusual items
-၄.၁၄ ကုဋေ
-၃.၈၈ ကုဋေ
-၄.၂၆ ကုဋေ
-၄.၂၇ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၄.၁၄ ကုဋေ
-၃.၈၈ ကုဋေ
-၄.၂၆ ကုဋေ
-၄.၂၇ ကုဋေ
Net profit margin
-
-
-
-၉၁၉.၇၆%
Earnings per share
-၀.၁၉
-၀.၁၇
-၀.၁၈
-၀.၁၃
Interest and investment income
၃.၉၃ သန်း
၃.၆၆ သန်း
၃.၅၇ သန်း
၄.၆၅ သန်း
Interest expense
-၃.၄၄ သိန်း
-၃.၁၃ သိန်း
-၃.၀၀ သိန်း
-၃.၄၃ သိန်း
Net interest expenses
၃.၅၈ သန်း
၃.၃၅ သန်း
၃.၂၇ သန်း
၄.၃၀ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၄.၁၈ ကုဋေ
-၃.၉၃ ကုဋေ
-၄.၃၂ ကုဋေ
-၄.၄၃ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google အက်ပ်များ